Other equities analysts have also issued reports about the company. Zacks Investment Research raised USANA Health Sciences from a hold rating to a strong-buy rating and set a $86.00 price objective for the company in a report on Saturday, October 26th. Jefferies Financial Group began coverage on USANA Health Sciences in a research report on Thursday, August 22nd. They issued a hold rating and a $65.00 target price on the stock. Two analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of Buy and an average price target of $74.00.
USNA stock opened at $73.11 on Tuesday. The stock has a market cap of $1.58 billion, a PE ratio of 14.17 and a beta of 0.30. The firm’s 50-day simple moving average is $73.21 and its 200 day simple moving average is $70.32. USANA Health Sciences has a fifty-two week low of $58.30 and a fifty-two week high of $125.61.
In related news, Director Robert Auciaux sold 4,018 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $71.87, for a total transaction of $288,773.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO G Doug Iiekking sold 1,746 shares of the firm’s stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $75.33, for a total value of $131,526.18. Following the transaction, the chief financial officer now directly owns 2,032 shares of the company’s stock, valued at approximately $153,070.56. The disclosure for this sale can be found here. Insiders sold 8,385 shares of company stock valued at $617,279 in the last ninety days. Corporate insiders own 42.50% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. lifted its stake in USANA Health Sciences by 72.6% during the second quarter. BlackRock Inc. now owns 2,302,511 shares of the company’s stock valued at $182,889,000 after buying an additional 968,239 shares in the last quarter. Nuveen Asset Management LLC purchased a new stake in shares of USANA Health Sciences in the 2nd quarter valued at approximately $17,458,000. Schroder Investment Management Group boosted its stake in USANA Health Sciences by 183.1% in the 2nd quarter. Schroder Investment Management Group now owns 212,492 shares of the company’s stock worth $16,878,000 after purchasing an additional 137,430 shares during the period. Wasatch Advisors Inc. boosted its stake in USANA Health Sciences by 127.0% in the 2nd quarter. Wasatch Advisors Inc. now owns 96,447 shares of the company’s stock worth $7,661,000 after purchasing an additional 53,960 shares during the period. Finally, State of New Jersey Common Pension Fund D purchased a new position in USANA Health Sciences during the 3rd quarter worth approximately $2,633,000. 52.87% of the stock is owned by institutional investors.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Recommended Story: Forex
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.